|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,187.00 INR | -1.77% |
|
-2.70% | -0.43% |
| 27/02 | Mankind Pharma says tax penalty of 10.2 million rupees dropped | RE |
| 16/02 | Mankind Pharma says tax penalty of 4.6 million rupees dropped | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 142.87Cr | 16.31% | 19.63% | 16.8% | 10.02% | 2.07x | ||
| 6.52TCr | 31.67% | 41.84% | 106.69% | 22.77% | 1.2x | ||
| 9.42TCr | 28.46% | 32.23% | 31.68% | 13.82% | 0.84x | ||
| 6.12TCr | 6.91% | 38.79% | 64,669.09% | 13.22% | 2.44x | ||
| 7.76TCr | 20.94% | 35.49% | 47.65% | 15.43% | 0.66x | ||
| 5.87TCr | 17.41% | 31.46% | 31.99% | 13.12% | 1.2x | ||
| 5.67TCr | 24.64% | 38.62% | 38.4% | 16.33% | 1.02x | ||
| 6.5TCr | 28.08% | 41.19% | 45.52% | 17.73% | 1.07x | ||
| 3.68TCr | 20.98% | 44.09% | 162.88% | 12.98% | 2.13x | ||
| 2.94TCr | 28.9% | 44.81% | 48.87% | 17.34% | 1.08x | ||
| 4.86TCr | 33.14% | 41.3% | 60.7% | 20.31% | 0.69x | ||
| 6.26TCr | 12.42% | 35.11% | 21.07% | 8.73% | 1.79x | ||
| 4.82TCr | 14.64% | 30.37% | 72.08% | 7.72% | 1.83x | ||
| 1.2TCr | 32.94% | 43.85% | 27.07% | 16.41% | -1.21x | ||
| 3.93TCr | 8.21% | 29.16% | 48.09% | 10.97% | 1.22x | ||
| 5.12TCr | 17.91% | 27.85% | 10.5% | 6.02% | 0.81x | ||
| 744.57Cr | 33.09% | 46.3% | 22% | 18.71% | -1.74x | ||
| 3.06TCr | 2.36% | 7.48% | 1.5% | 1.19% | 3.6x | ||
| 383.4Cr | 22.64% | 26.77% | 14.73% | 13.49% | -2.98x | ||
| 1.41TCr | 12.84% | 22.26% | 8.8% | 4.22% | 2.82x | ||
| Average | 4.32TCr | 20.72% | 33.93% | 3,274.31% | 13.03% | 1.03x | |
| Weighted average by Cap. | 5.92TCr | 23.38% | 37.22% | 5,896.61% | 15.66% | 1.12x |
- Stock Market
- Equities
- MANKIND Stock
- Sector Mankind Pharma Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















